Stay updated with breaking news from Nancy Kohlberg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lenvatinib plus pembrolizumab displayed a superior clinical benefit vs sunitinib irrespective of patient biomarker subtype in advanced clear cell RCC.
Now, 40 years since its founding, The Martha’s Vineyard Times once again doubles down to its news-gathering overwatch on Islanders’ behalf. And once again, although a new crowd is at the controls, the job is the same, and it is a familiar one. Newspapering is comfortably at home on Martha’s Vineyard. And because Islanders are […]
Paul V. Viscuse, MD, spotlights key data from the 2024 Genitourinary Cancers Symposium in bladder cancer and renal cell carcinoma.
RAHWAY - Merck , known as MSD outside of the United States and Canada, today announced results from the Phase 3 KEYNOTE-564 trial evaluating KEYTRUDA, Merck's anti-PD-1 therapy, for the adjuvant...
Patients with clear cell renal cell carcinoma had improved overall survival when treated with adjuvant Keytruda compared to placebo.